The Use of Scan Pet for Lung Cancer
Volume 1 - Issue 4
Daniela Vazquez Capdepon*
DOI: 10.26717/BJSTR.2017.01.000124
-
Author Information
Open or Close
- Medical Director of the Centro Oncológico campana, Argentina
*Corresponding author:
Daniela Vazquez Capdepón, Medical Director of the Centro Oncológico campana, Oncologist of the Perú Hospital Gral. Galarza,
Oncologist of the Centro Medico San José, French 374 – Campana, Pacia. BS. AS.
Received: June 06, 2017 Published: June 09, 2017
To view the Full Article Peer-reviewed Article PDF
Abstract
Lung cancer is the most common cause of cancer death
in Western countries, and non-small cell lung cancer (NSCLC)
accounts for 80% of these neoplasms. Despite the efforts in the
early diagnosis and advances in the treatment of these patients,
overall survival remains very low, approximately 18% at 5 years2.
The relatively low (30-50%) survival of patients with limited,
potentially curable disease probably reflects the inability to detect
advanced disease at initial staging
Opinion |
Conclusion |
Figures |
ISSN: 2574 -1241
